Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 1, 2022

Mesh Bio, MultiOmic partner to develop chronic metabolic disease medicines

Digital health start-up Mesh Bio has collaborated with drug discovery company MultiOmic Health to use artificial intelligence (AI) for developing precision medicines and diagnostics for chronic metabolic disease.

Continue
Mesh Bio and MultiOmic Health will use artificial intelligence to develop precision medicines and diagnostics for chronic metabolic disease. Credit: Mesh Bio Pte. Ltd.
June 30, 2022

Generian, Astellas to develop molecules for undruggable therapeutic targets

June 14, 2022

ImmunoGen, OBT partner to develop new antibody-drug conjugates for cancers

ImmunoGen and Oxford BioTherapeutics will use their respective technologies to develop new antibody-drug conjugates. Credit: National Cancer Institute on Unsplash.

Contracts

June 16, 2022

Quoin Pharmaceuticals signs license, distribution agreement with WinHealth Pharma

Image: Netherton Syndrome is a rare genetic disease impacting the skin and immune system. Credit: andreas160578 from Pixabay.

Intravac signs licensing deal with Zhifei Lvzhu for whooping cough vaccine

Ardelyx amends license deal with Kyowa Kirin for tenapanor

Clovis Oncology, Evergreen partner for actinium-225-labeled FAP-2286

Deals

Deals June 15, 2022

Boehringer Ingelheim signs option to acquire Trutino Biosciences

Pharmaceutical Business Review

Castle Creek Biosciences raises $112.8m to progress gene therapies

Inceptor Bio raises $37m from Series A to advance CAR-T lead programme

SwanBio raises $56m to advance new gene therapies for neurological conditions

Popular

  1. Janssen secures FDA breakthrough designation for myeloma therapy
  2. Palleon, Henlius partner for bifunctional sialidase therapies development
  3. Sanofi receives marketing authorisation from EC for Pompe disease therapy
  4. EMA’s CHMP recommends approval for AbbVie’s axial spondyloarthritis therapy
  5. EC approves Novartis’ Cosentyx to treat arthritis in children

PRESS RELEASES

Pharmaceutical Business Review
NSF is Expanding its Most Popular Virtual, Instructor-Led Pharmaceutical Courses to Run at Times Convenient for North American Delegates
Customer Need Leads to New Denny Bros Product
Customer Need Leads to New Denny Bros Product
LTS Academy: Introducing Oral Thin Films as a Viable Dosage Form for Pain Relief
LTS Academy: Introducing Oral Thin Films as a Viable Dosage Form for Pain Relief
SGS Advances Clinical Trial Data Management with Veeva Vault EDC
SGS Advances Clinical Trial Data Management with Veeva Vault EDC
Gerresheimer Partners with MedTech Start-up Adamant Health to Revolutionise Treatment of Parkinson’s Disease
Gerresheimer Partners with MedTech Start-up Adamant Health to Revolutionise Treatment of Parkinson’s Disease

Suppliers

Whitepapers

Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Deeper Insight into the Pyrolysis of Acetylsalicylic Acid by Means of Kinetic Analysis
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Deuterium-Containing Building Blocks for Drug Design
Deuterium-Containing Building Blocks for Drug Design